Mani, Inc. (JP:7730)
:7730
Want to see JP:7730 full AI Analyst Report?
7730 Stock Chart & Stats
¥1500.50
¥30.00(1.62%)
At close: 4:00 PM EST
¥1500.50
¥30.00(1.62%)
Day’s Range― - ―
52-Week Range¥1,171.50 - ¥1,955.00
Previous CloseN/A
Volume546.10K
Average Volume (3M)283.94K
Market Cap
¥168.66B
Enterprise Value¥143.79B
Total Cash (Recent Filing)¥18.73B
Total Debt (Recent Filing)¥76.00M
Price to Earnings (P/E)26.4
Beta0.99
Next Earnings
Jul 15, 2026EPS Estimate
19.98Next Dividend Ex-DateN/A
Dividend Yield2.73%
Share Statistics
EPS (TTM)54.49
Shares Outstanding107,003,280
10 Day Avg. Volume284,170
30 Day Avg. Volume283,943
Financial Highlights & Ratios
PEG Ratio-1.02
Price to Book (P/B)2.31
Price to Sales (P/S)4.12
P/FCF Ratio201.91
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)74.29
Revenue Forecast (FY)¥33.31B
Bulls Say, Bears Say
Bulls Say
High Gross & EBIT MarginsSustained high gross and operating margins indicate durable product-level pricing power and efficient operations. This margin buffer helps absorb input cost shocks, funds R&D and distribution, and supports long-term profitability even if top-line growth slows.
Very Conservative Balance SheetExtremely low leverage and a growing equity base materially reduce solvency and refinancing risk, giving the company flexibility to fund capex, acquisitions, or dividends internally. This structural strength supports resilience through economic cycles.
Recurring Consumable Sales & Steady Revenue GrowthMulti-year revenue expansion combined with a business model selling consumable dental products supports predictable repeat demand and revenue visibility. Recurring consumables underpin stable cash inflows and customer stickiness over the medium term.
Bears Say
Compressed And Volatile Free Cash FlowSharp FCF compression and volatility weaken the company’s ability to return capital or self-fund growth despite strong operating margins. Persistent low FCF points to higher capex or working-capital needs, reducing financial flexibility over the coming quarters.
Net Margin DeteriorationDeclining net margin despite healthy gross and EBIT margins suggests pressure below the operating line (e.g., higher non-op costs, taxes, or financing). If sustained, lower net margins reduce retained earnings and long-term return on capital.
Slowing Revenue Growth And EPS ContractionA meaningful slowdown in topline expansion and negative EPS growth signal potential market saturation or competitive pressures. Over several quarters this can limit scale economies, pressure investment returns, and constrain medium-term earnings momentum.
7730 FAQ
What was Mani, Inc.’s price range in the past 12 months?
Mani, Inc. lowest stock price was ¥1171.50 and its highest was ¥1955.00 in the past 12 months.
What is Mani, Inc.’s market cap?
Mani, Inc.’s market cap is ¥168.66B.
When is Mani, Inc.’s upcoming earnings report date?
Mani, Inc.’s upcoming earnings report date is Jul 15, 2026 which is in 24 days.
How were Mani, Inc.’s earnings last quarter?
Mani, Inc. released its earnings results on Apr 14, 2026. The company reported ¥20.33 earnings per share for the quarter, beating the consensus estimate of ¥17.417 by ¥2.913.
Is Mani, Inc. overvalued?
According to Wall Street analysts Mani, Inc.’s price is currently Overvalued.
Does Mani, Inc. pay dividends?
Mani, Inc. pays a Semiannually dividend of ¥24 which represents an annual dividend yield of 2.73%. See more information on Mani, Inc. dividends here
What is Mani, Inc.’s EPS estimate?
Mani, Inc.’s EPS estimate is 19.98.
How many shares outstanding does Mani, Inc. have?
Mani, Inc. has 107,003,280 shares outstanding.
What happened to Mani, Inc.’s price movement after its last earnings report?
Mani, Inc. reported an EPS of ¥20.33 in its last earnings report, beating expectations of ¥17.417. Following the earnings report the stock price went down -0.321%.
Which hedge fund is a major shareholder of Mani, Inc.?
Currently, no hedge funds are holding shares in JP:7730
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Mani, Inc.
Mani, Inc., a company established in Utsunomiya, Japan, in 1956, operates as a prominent player in the global healthcare technology sector. The firm specializes in the research, development, manufacturing, and worldwide distribution of sophisticated medical and dental instruments. Its diverse range of medical offerings includes various surgical tools such as maniplers, vessel knives, general knives, stainless steel wire needles, and saws, which are indispensable for tasks like incision, cutting, and suturing during surgical procedures. For ophthalmic care, the company provides specialized instruments like eye sutures, surgical knives, and trocar kits, essential for intricate eye operations, notably cataract surgeries. Furthermore, Mani, Inc. produces both eyeless and eyed surgical needles. In the dental field, the company delivers a comprehensive assortment of products. This includes a variety of endodontic instruments (both standard and rotary), materials for root canal obturation, diamond and carbide burs, finishing and polishing instruments, dental sutures and surgical needles, as well as specialized micro-accessories and general accessories for endodontics. Beyond its manufacturing activities, Mani, Inc. also engages in the import and distribution of other medical devices.
Technical Analysis
Options Prices
Currently, No data available
---